Rapid Antigen Covid Tests from Fosun. Fosun is one of the largest pharma factories in the world and has US FDA EUA certification. Pic and brochure attached.
MOQ 250,000 pieces
FOB China: with FDA CLIA
TT with 30% deposit: US$ 1.80 per piece
FOB China: with EUA
TT with 30% deposit: US$ 1.45 per piece
Features
* Testing principle: Immunofluorescence assay, better sensitivity and specificity than
colloidal gold assay.
- In vitro diagnostics(IVD) Kits
- Designed for the qualitative detection of COVID-19 viral RNA
- Oropharyngeal swab, nasopharyngeal swab, sputum and bronchoalveolar lavage (BAL)
- Store at -25~ -15
Product description:
Detects the novel coronavirus.
COVID-19 using one-step real-time RT-PCR in a single tube.
The target genes for the detection of the virus are Orf1ab and N gene.
The sequence of primers and probes for the amplification were adapted from sources published by China CDC and WHO.
The kit includes primers and probe for the amplification of the human RNase P gene that serves as an internal positive control for the real-time RT-PCR.
Compatible real-time PCR machines: CFX96(Bio-Rad), ABI 7500/7500Fast(Thermo Fisher Scientific), SLAN-96S(Hongshi), Rotor-Gene Q(QIAGEN)
- Store at room temperature
- Whole turnaround time, from sample collection to result analysis, can be as short as 50 minutes.
- All in one packaging: RNA extracted from a specimen can be simply loaded in premixed, aliquoted 8 strip tubes to perform PCR.
Without a need for pre-PCR preparation step, it not only reduces risks of contamination but also workload of healthcare operators.
5096 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
Globally acclaimed Covid Test kits , the best of brands with CE and other requisite certificates are available at a fantastic price ( PanBio/ Flowflex/ Sd Bio sensor) . Delivery all over the globe in 2/ 5 days vide air cargo. We hold the biggest stocks in India. Pl note , prices are quantum based and fluctuate as per demand and supply.
This device is a qualitative serology test based on immunochromatography. The appearance of a coloured band indicates the presence of the antibody within 10 minutes.
The test can be used for vaccination control.
This test controls two types of antibodies in parallel: IgM and IgG.
The IgM antibody level starts to be truly detectable about a week after the initial infection, while IgG usually appears within 14 days of infection and can last for several months or even years.
The device is now approved by the Ministry of Health.
Using two drops of blood, the test can detect COVID-19 in less than 10 minutes. The test is based on the detection of antibodies specific to the disease.
The test has the advantage of giving a result during and after contamination.
The specificity of the test (IgM and IgG) is 100% (study carried out by different hospitals).
The sensitivity of the test is 92.8% for IgM antibodies and 96.5% for IgG antibodies for false negatives (1300 tests).
The performance values of our device are in line with the recommendations of the Haute Autorit de Sant (HAS)
The test have been approved and controlled by French government (ANR: Pasteur)
Ezple Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction.
MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM).
HP-CLA Real-time PCR kit is an in vitro diagnostic test that qualitatively detects helicobacter pylori and Clarithromycin-resistant mutations from human gastric biopsy tissues. Contains multiple gene targets to detect Helicobacter clarismycin-resistant mutations. Genetree Viewer analysis software is provided, allowing users to conveniently check results.
SFTS Virus Real-time PCR Kit is an in vitro diagnostic test intended for the qualitative detection of the Dabie bandavirus that causes Severe Fever with thrombocytopenia Syndrome using nucleic acid RNA extracted from human blood or serum. Clinical evaluation performed with human blood specimens confirmed clinical accuracy. High reproducibility with similar results were confirmed various tests.
HLA-DRB1 NGS typing Kit is an in vitro diagnostic test that detects and distinguishes allelic genes of HLA-DRB1 in human leukocyte antigens at high resolution using next-generation sequencing. Ezplex's unique amplicon approach simplifies the traditional complex NGS Library construction process and provides dedicated software optimized for HLA typing for easy analysis. The Ezplex�® HLA-DRB1 NGS typing Kit accurately reads the HLA-type Acuracy % (95% Confidence Interval) in DRB1 Locus within a total of 35 hours from DNA extraction to NGS results analysis to help with pre-transplant testing.
Helicobacter pylori is a parasitic bacterium in the stomach that lives between the gastric mucosa and mucus. According to the WHO, more than half of the world's population has H. pylori and is the third leading cause of cancer-related deaths. In 1994, the WHO's IARC classified H. Pylori as a Class 1 carcinogen. The incidence of H. pylori in developing countries is the highest worldwide, highlighting the need for highly accurate and manageable testing. By 2025, the H. pylori testing market is expected to be worth 6 billion. Accordingly, SML Genetree has developed a reagent that can diagnose Helico-bacter pylori and Clarithromycin-resistant mutants (A2142G, A2143G) through DNA extracted from human hygienic tissue using Real-time Polymerase Chain Reaction. Since it contains multiple gene regions, Helico-bacter pylori and Clarithromycin-resistant mutations can be detected sensitively, and high reproducibility has been demonstrated through repeated tests by serially diluting various positive samples and standards. In addition, as a result of clinical evaluation on human sanitary inspection tissue by commissioning a large domestic consignment inspection institution, high sensitivity and specificity were confirmed, proving its excellent clinical performance.
HPV is a virus that causes papillomas (benign tumors), and about 200 types have been discovered so far. Some types of HPV are known to be the direct cause of cervical cancer, head and neck cancer, etc. In particular, in the case of cervical cancer, more than 99% of the causes are reported to be caused by HPV. If it is detected early, it is easy to treat, but if it is detected late, the 5-year survival rate is less than 15% even with treatment, so regular check-ups are very important. SML Genetree has developed the world's first Ezplex�® HPV NGS Kit to diagnose HPV using the NGS method. Unlike the existing methods that only detected up to 20 to 40 types and only positive-negative, NGS was introduced to provide positive results for 45 types of HPV (up to 100 types including for export) according to the amount of DNA detected in steps 1 to 3 Semi-quantitative inspection of the level is possible. It has a high level of automation that is close to full automatic. The time has been shortened so that up to 480 people can be analyzed within 16 hours with one analysis, and it is possible to distinguish HPV species that were difficult to distinguish precisely. Unlike the existing sequencing method, the NGS method has been highly evaluated for its potential as a precision medical technology that can dramatically reduce time and cost by analyzing numerous DNAs at high speed. As a result of clinical efficacy evaluation with more than 2500 clinical specimens in large domestic hospitals, it is a product with high sensitivity and specificity compared to existing tests.
Ezplex�® SARS-CoV-2 G Kit, developed by SML Genetree, is a product that has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This is an in vitro diagnostic test that qualitatively detects the nucleic acids of SARS-CoV-2 (RdRp and N genes) in sputum to aid in emergency screening for COVID-19. This product can be used for a large amount of screening tests because it can perform a pooling test, unlike the products that the existing domestic companies have approved for emergency use by the FDA. For the combined test, samples are collected in units of 5 people and tested. If positive, individual tests are performed. In the case of a negative test, all tests are performed in a negative way. In particular, since a large number of samples are tested at once, the test is only possible with high sensitivity and specificity compared to existing diagnostic kits. According to the FDA, it was confirmed that 100% agreement was achieved in the result comparison test of individual and collective tests, and it was the 20th in the world and the first Korean company to pass the test. Excellent clinical performance was demonstrated by confirming high sensitivity and specificity through clinical evaluation, and stability was confirmed for 12 months through long-term storage tests. In January 2021, it was officially approved by the Korean Ministry of Food and Drug Safety (MFDS).
Ezplex MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM).
Sensitivity : Multiple gene targets for MTBC and NTM.
Clinical Performance: Validated clinical performance.
Fast Results: Testing can be completed within 2 hours post extraction.
5096 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
